Analyst Ratings for Eagle Pharmaceuticals Inc. (EGRX)

Updated: 2017-07-28

An average rating of Overweight has been given to Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) by analysts covering the stock. EGRX had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 3 analysts, 0 gave an overweight rating, 0 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for EGRX. The maximum price target given was 118, implying a possible profit of 132.47 percent. The minimum price target given was 57, implying potential capital losses of 12.29 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is -23.85 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -6.27 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

Analysts estimate earnings of EGRX to grow at a rate of -46.64 percent. People on Wall Street often look at a company's PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of EGRX is -0.17.

In the last 52-weeks, EGRX has achieved a high of 97.15 and a low of 42.33. Currently the stock is 19.91 percent higher than its low, and 47.75 percent below the high. EGRX has a P/E ratio of 7.87. Investors typically compare the P/E ratio to a company's peers in the industry. The EGRX value stock report compares EGRX to some of its peers using value stock charts. The stock has a market capitalization of $0.80613 billion. EGRX will post this quarters earnings in days, on 0000-00-00.